• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

adhd medication cost Medication During Pregnancy and Breastfeeding

Women suffering from ADHD must make a difficult decision on whether to keep or stop taking ADHD medication during pregnancy and breast-feeding. There aren't enough data on how does adhd medication work for adults exposure to ADHD for a long time could affect a pregnant fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication in utero do not develop neurological conditions like hearing loss or impaired vision seizures, febrile seizures or IQ impairment. The authors acknowledge that more high-quality studies are required.

Risk/Benefit Analysis

Pregnant women who take ADHD medications need to balance the advantages of taking them against the potential risks to the foetus. Doctors don't have enough data to give clear advice, but can provide information on the risks and benefits to help pregnant women make informed choices.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication during their early pregnancy were not at a higher risk of fetal malformations, or structural birth defects. The researchers used a large population-based study of case-control to evaluate the incidence of major structural birth defects in infants born to mothers who had taken stimulants during the early stages of pregnancy, and those who did not. Clinical geneticists and pediatric cardiologists examined the cases to ensure an accurate classification of the cases and to reduce the chance of bias.

The study conducted by the researchers had some limitations. most effective adhd medication important, they were unable to separate the effects of the medication from the effects of the underlying disorder. That limitation makes it difficult to know whether the limited associations observed in the groups that were exposed result from medication use or confounding by comorbidities. The researchers did not examine long-term outcomes for the offspring.

The study showed that babies whose mothers had taken ADHD medication during pregnancy were at a slightly greater risk of being admitted to the neonatal care unit (NICU) as compared to mothers who did not take any medication during pregnancy or quit taking the medication prior to or during pregnancy. This was due to central nervous system disorders, and the increased risk for admission did not appear to be affected by the type of stimulant medications were used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher risk of having to have a caesarean section or one whose baby scored low on the Apgar scale (less than 7). These increases did not seem to be influenced by the type of medication that was used during pregnancy.

The research suggests that the risk of a small amount with the use of ADHD medications during the early stages of pregnancy could be offset by the greater benefit to both the mother and child of continuing treatment for the woman's disorder. Physicians should speak with their patients about this issue and as much as possible, assist them develop coping strategies that could reduce the impact of her disorder in her daily life and relationships.

Medication Interactions

As more women than ever are being diagnosed with ADHD and being treated with medication, the issue of whether or not to end treatment during pregnancy is one that more and more physicians confront. These decisions are usually made without clear and authoritative evidence. Instead, physicians must weigh their own knowledge, the experience of other doctors and the research that has been conducted on the subject.

The issue of possible risks to the infant can be difficult to determine. A lot of studies on this topic are based on observational evidence rather than controlled research and their conclusions are often contradictory. Furthermore, most studies restrict their analysis to live births, which could underestimate the severity of teratogenic effects that could lead to abortion or termination of the pregnancy. The study presented in this journal club addresses these limitations by looking at data from both live and deceased births.

Conclusion Some studies have found an association between ADHD medications and certain birth defects However, other studies haven't established a link. Most studies show that there is a neutral, or somewhat negative, impact. In every case it is imperative to conduct a thorough study of the benefits and risks must be performed.

It isn't easy, but not impossible, for women suffering from ADHD to stop taking their medication. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of being isolated. Furthermore, a loss of medication may affect the ability to do job-related tasks and drive safely which are essential aspects of daily life for a lot of people with ADHD.

She recommends women who are uncertain about whether or not to stop medication in light of their pregnancy, consider the possibility of educating friends, family members and colleagues about the condition, its effects on daily functioning, and on the advantages of staying on the current treatment regimen. It will also help a woman feel confident about her decision. Certain medications can pass through the placenta. If a patient decides to not take her ADHD medication while pregnant and breastfeeding, it is important to be aware that the medication could be transferred to the infant.

Birth Defects Risk

As the use and abuse of ADHD drugs to treat symptoms of attention deficit disorder hyperactivity disorder (ADHD) is increasing, so does concern about the potential effects of these drugs on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this subject. Utilizing two huge data sets researchers were able to examine more than 4.3 million pregnancies and see whether the use of stimulant medications increased the risk of birth defects. Researchers discovered that, while the risk overall is low, the first trimester ADHD medication use was associated with slightly higher rates of certain heart defects, like ventriculoseptal defect.

The authors of the study found no connection between the use of early medications and other congenital anomalies, like facial clefting, or club foot. The results are consistent with previous studies that have shown an increase, but not significant, in the risk of heart malformations among women who started taking ADHD medications prior to the time of pregnancy. This risk increased during the latter part of pregnancy, when a lot of women decided to stop taking their medication.

Women who were taking ADHD medication in the first trimester were more likely require a caesarean birth, have an insufficient Apgar after delivery, and had a baby that required breathing assistance after birth. The authors of the study were not able to remove bias in selection since they restricted the study to women who did not have any other medical conditions that might have contributed to the findings.

The researchers hope their study will serve to inform the clinical decisions of doctors who see pregnant women. They advise that while a discussion of the benefits and risks is important but the decision to stop or maintain treatment should be based on each woman's needs and the severity of her ADHD symptoms.

The authors caution that, even though stopping the medication is a possibility to think about, it isn't advised because of the high incidence of depression and mental health issues for women who are pregnant or recently gave birth. Research has also shown that women who stop taking their medications will have a harder adjustment to life without them once the baby is born.

Nursing

The responsibilities that come with being a new mother can be overwhelming. Women with adhd medication pregnancy are often faced with a number of difficulties when they must deal with their symptoms, go to doctor appointments, prepare for the birth of a child and adjust to new routines. As such, many women choose to continue taking their ADHD medications throughout pregnancy.

The risk for breastfeeding infant is not too high since the majority of stimulant medications passes through breast milk at a low level. However, the frequency of exposure to medication by the newborn can vary depending on dosage, how often it is administered, and the time of day the medication is administered. Additionally, individual medications enter the body of the baby differently through the gastrointestinal tract as well as breast milk. The impact of this on a newborn isn't yet fully understood.

Some physicians may discontinue stimulant medications during a woman's pregnancy due to the absence of research. This is a difficult decision for the woman, who must weigh the benefits of taking her medication as well as the potential risks to the fetus. As long as there is no more information, doctors should inquire with all pregnant patients about their history of ADHD and if they plan or are taking to take medication during the perinatal period.

Numerous studies have demonstrated that women can continue to take their ADHD medication safely while breastfeeding and during pregnancy. As a result, an increasing number of patients opt to do this and, after consulting with their doctor, they have found that the benefits of keeping their current medication far outweigh any risks.

Women who suffer from ADHD who are planning to breastfeed should seek advice from a specialist psychiatrist before becoming pregnant. They should discuss their medication with their physician and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological strategies. Psychoeducation is also required to help pregnant women suffering from ADHD be aware of their symptoms and the root cause Learn about the available treatment options and reinforce existing strategies for coping. This should be an approach that is multidisciplinary, including the GP doctors, obstetricians and psychiatrists. Counselling for pregnancy should include discussion of a management plan for both the mother as well as the child, and monitoring for signs of deterioration and the need for adjustments to the medication regimen.